Ceribell, Inc. Files Proxy Statement Amendment

Ticker: CBLL · Form: DEFA14A · Filed: Jun 9, 2025 · CIK: 1861107

Ceribell, INC. DEFA14A Filing Summary
FieldDetail
CompanyCeribell, INC. (CBLL)
Form TypeDEFA14A
Filed DateJun 9, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, proxy-statement, amendment

TL;DR

Ceribell filed an update to its proxy statement, no fee required.

AI Summary

Ceribell, Inc. filed an amendment (Amendment No. 1) to its Schedule 14A on June 9, 2025. This filing is considered Definitive Additional Materials and does not require a filing fee. The company, based in Sunnyvale, CA, operates in the electromedical and electrotherapeutic apparatus industry.

Why It Matters

This filing is a routine regulatory update for Ceribell, Inc., indicating ongoing corporate actions and disclosures required by the SEC for publicly traded companies.

Risk Assessment

Risk Level: low — This filing is a standard amendment to a proxy statement and does not contain information that inherently increases risk for investors.

Key Players & Entities

FAQ

What type of filing is this amendment?

This filing is an amendment to Ceribell, Inc.'s Schedule 14A, specifically classified as Definitive Additional Materials.

When was this filing submitted?

The filing was submitted on June 9, 2025.

Is there a filing fee associated with this amendment?

No, the filing fee section indicates 'No fee'.

What is Ceribell, Inc.'s primary business classification?

Ceribell, Inc. is classified under Standard Industrial Classification 3845: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.

Where is Ceribell, Inc. located?

Ceribell, Inc.'s business and mailing address is 360 N. PASTORIA AVENUE, SUNNYVALE, CA 94085.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 9, 2025 regarding Ceribell, Inc. (CBLL).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing